CYP2C19 or CYP3A4 Inhibitors Clinical Impact: Increased exposure of dexlansoprazole is expected when used concomitantly with strong inhibitors [see CLINICAL PHARMACOLOGY]. Intervention: Voriconazole: See prescribing information. Warnings for Dexilant and Dexilant SoluTabs Included as part of the PRECAUTIONS ...
The incidence of common adverse events in Table 3 below is based upon pooled data from two double-blind, placebo-controlled lung function clinical studies (6 and 12 months in duration) in which 771 adult COPD patients (496 males and 275 females) 40 years of age and older were treated with...
Six DILI-negative third-generation cephalosporins were added against a background of zero in DILIrank. Also, there were one or two DILI-negative drugs added to three chemical categories (protease inhibitors, ACE inhibitors, and fluoroquinolones) where there were no DILI-negative drugs listed ...
aCaution should be used when administering or taking TARCEVA with ketoconazole and other strong CYP3A4 inhibitors such as, but not limited to, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, troleandomycin (TAO), voriconazole and grapefr...
nucleotides,APIs,carbohydrates,nucleosides,stem cell molecule,inhibitors,ADCs,chiral compounds,building blocks,natural compounds,GMP Products Inquiry Val-cit-PAB-OH CAS No.: 159857-79-1 Grade: Industrial Grade Content: 99% Packaging: 25kg/Cardboard Drum Shaanxi Dideu Medichem Co. Ltd Manufact...
Imaging the Intracellular Distribution of Tyrosine Kinase Inhibitors in Living Cells with Quantitative Hyperspectral Stimulated Raman Scattering D. Fu, J. Zhou, W.S. Zhu, P.W. Manley,Y.K. Wang, T. Hood, A. Wylie, X.S. Xie Nat Chem. 2014 Jul; 6(7): 614–622. doi: 10.1038/nchem....
PPP1R3A, ID (PPP1R3A, PP1G, Protein phosphatase 1 regulatory subunit 3A, Protein phosphatase 1 glycogen-associated regulatory subunit, Protein phosphatase type-1 glycogen targeting subunit) (FITC)Details RIC8A (Resistance to Inhibitors of Cholinesterase 8 Homolog A (C. elegans), MGC104517, MGC1...
基因名疾病靶向药化疗药基因突变临床解释 MLH1林奇综合征,胃癌奥沙利铂,2828 MTOR膀胱癌,乳腺癌,透明细胞肾细胞癌,子宫内膜腺癌,黑色素瘤,肾细胞癌,实体瘤,T细胞急性淋巴细胞白血病,甲状腺癌,尿路上皮癌Capivasertib,AZD8055,依维莫司,LY294002,MTOR Inhibitors,帕唑帕尼,培唑帕尼,RapaLink-1,西罗莫司,雷帕...
that is tumour angiogenesis. Significant research has therefore focussed on angiogenesis inhibitors as a means to prevent the growth of metastases. Despite these findings, however, the effective treatment of metastatic cancer has been elusive and largely still relies on the application of very non-spec...
An apparatus for enhancing, structuring and/or pre-structuring oxygen includes a vessel having an inlet and an outlet so as to allow oxygen to pass therethrough, a pair of screens positioned within th